BRIGATINIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 39 adverse event reports in the FDA FAERS database where BRIGATINIB was used for Neoplasm malignant.
Most Reported Side Effects for BRIGATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 405 | 12.3% | 404 | 70 |
| Non-small cell lung cancer | 370 | 11.3% | 69 | 63 |
| Off label use | 256 | 7.8% | 64 | 73 |
| Diarrhoea | 239 | 7.3% | 29 | 91 |
| Metastases to central nervous system | 219 | 6.7% | 33 | 40 |
| Nausea | 218 | 6.6% | 24 | 89 |
| Lung neoplasm malignant | 216 | 6.6% | 38 | 36 |
| Fatigue | 201 | 6.1% | 26 | 61 |
| Blood creatine phosphokinase increased | 198 | 6.0% | 10 | 42 |
| Product dose omission issue | 193 | 5.9% | 18 | 70 |
| Neoplasm progression | 172 | 5.2% | 32 | 24 |
| Drug ineffective | 171 | 5.2% | 33 | 31 |
| Vomiting | 122 | 3.7% | 23 | 47 |
| Dyspnoea | 121 | 3.7% | 21 | 52 |
| Cough | 112 | 3.4% | 19 | 37 |
Other Indications for BRIGATINIB
Non-small cell lung cancer (1,130)
Lung neoplasm malignant (946)
Product used for unknown indication (513)
Lung adenocarcinoma (148)
Non-small cell lung cancer metastatic (82)
Neurofibromatosis (70)
Lung adenocarcinoma stage iv (60)
Bronchial carcinoma (30)
Lung cancer metastatic (30)
Non-small cell lung cancer stage iv (29)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)